| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Division of Cellular and Molecular Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15261
Hepatocyte growth factor (HGF) and Wnt signaling pathways have been shown to be important in embryogenesis and carcinogenesis. The aim of this study was to elucidate the mechanism of functional similarities observed in the two pathways. We used normal rat liver, primary hepatocyte cultures and a dominant-negative Met expression system to study the effect of HGF on Wnt pathway components. We demonstrate novel association of ß-catenin and Met, a tyrosine kinase receptor of HGF, at the inner surface of the hepatocyte membrane. HGF induces dose-dependent nuclear translocation of ß-catenin in primary hepatocyte cultures that is Wnt independent. The source of ß-catenin for translocation in hepatocytes is the Met-ß-catenin complex, which appears to be independent of the E-cadherin-ß-catenin complex. To test the functionality of this association, we used a dominant-negative Met expression system that expresses only the extracellular and transmembrane regions of the ß-subunit of Met. A loss of Met-ß-catenin association resulted in abrogation of nuclear translocation of ß-catenin upon HGF stimulation. This event is tyrosine phosphorylation dependent, and the association of Met and ß-catenin is crucial for this event. We conclude that the HGF causes similar redistribution of ß-catenin as Wnt-1 in the hepatocytes and that this effect is attributable to subcellular association of Met and ß-catenin. The intracellular kinase domain of Met is essential for tyrosine phosphorylation and nuclear translocation of ß-catenin. Part of the multifunctionality of HGF might be attributable to nuclear ß-catenin and the resulting target gene expression.
This article has been cited by other articles:
![]() |
H. L. Palka-Hamblin, J. J. Gierut, W. Bie, P. M. Brauer, Y. Zheng, J. M. Asara, and A. L. Tyner Identification of {beta}-catenin as a target of the intracellular tyrosine kinase PTK6 J. Cell Sci., January 15, 2010; 123(2): 236 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goldoni, A. Humphries, A. Nystrom, S. Sattar, R. T. Owens, D. J. McQuillan, K. Ireton, and R. V. Iozzo Decorin is a novel antagonistic ligand of the Met receptor J. Cell Biol., May 18, 2009; 185(4): 743 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jean, A. Blanc, N. Prade-Houdellier, L. Ysebaert, H. Hernandez-Pigeon, T. Al Saati, M.-J. Haure, A.-M.-L. Coluccia, M. Charveron, E. Delabesse, et al. Epidermal Growth Factor Receptor/{beta}-Catenin/T-Cell Factor 4/Matrix Metalloproteinase 1: A New Pathway for Regulating Keratinocyte Invasiveness after UVA Irradiation Cancer Res., April 15, 2009; 69(8): 3291 - 3299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. David, A. Yeramian, M. Dunach, M. Llovera, C. Canti, A. G. de Herreros, J. X. Comella, and J. Herreros Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential {beta}-catenin phosphorylation J. Cell Sci., August 15, 2008; 121(16): 2718 - 2730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Litten and G. E. Tomlinson Liver Tumors in Children Oncologist, July 1, 2008; 13(7): 812 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marsh, S. Dickinson, G. W. Neill, J. F. Marshall, I. R. Hart, and G. J. Thomas {alpha}v{beta}6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation Cancer Res., May 1, 2008; 68(9): 3295 - 3303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Gujral, W. van Veelen, D. S. Richardson, S. M. Myers, J. A. Meens, D. S. Acton, M. Dunach, B. E. Elliott, J. W.M. Hoppener, and L. M. Mulligan A Novel RET Kinase-{beta}-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma Cancer Res., March 1, 2008; 68(5): 1338 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ye, D. Hu, L. Tu, X. Zhou, F. Lu, B. Wen, W. Wu, Y. Lin, Z. Zhou, and J. Qu Involvement of PI3K/Akt Signaling Pathway in Hepatocyte Growth Factor-Induced Migration of Uveal Melanoma Cells Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Tward, K. D. Jones, S. Yant, S. T. Cheung, S. T. Fan, X. Chen, M. A. Kay, R. Wang, and J. M. Bishop Distinct pathways of genomic progression to benign and malignant tumors of the liver PNAS, September 11, 2007; 104(37): 14771 - 14776. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Apte, G. Zeng, M. D. Thompson, P. Muller, A. Micsenyi, B. Cieply, K. H. Kaestner, and S. P. S. Monga beta-Catenin is critical for early postnatal liver growth Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1578 - G1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lutterbach, Q. Zeng, L. J. Davis, H. Hatch, G. Hang, N. E. Kohl, J. B. Gibbs, and B.-S. Pan Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival Cancer Res., March 1, 2007; 67(5): 2081 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Anderson, R. Harrison, P. A. Atherfold, M. J. Campbell, S. J. Darnton, J. Obszynska, and J. A.Z Jankowski Met receptor signaling: a key effector in esophageal adenocarcinoma. Clin. Cancer Res., October 15, 2006; 12(20): 5936 - 5943. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Peruzzi, G. Athauda, and D. P. Bottaro The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells PNAS, September 26, 2006; 103(39): 14531 - 14536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazzone and P. M. Comoglio The Met pathway: master switch and drug target in cancer progression FASEB J, August 1, 2006; 20(10): 1611 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakaigawa, M. Yao, M. Baba, S. Kato, T. Kishida, K. Hattori, Y. Nagashima, and Y. Kubota Inactivation of von Hippel-Lindau Gene Induces Constitutive Phosphorylation of MET Protein in Clear Cell Renal Carcinoma. Cancer Res., April 1, 2006; 66(7): 3699 - 3705. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Xu, Y.-Q. Zhou, and M.-H. Wang Mechanisms of Cytoplasmic {beta}-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase J. Biol. Chem., July 1, 2005; 280(26): 25087 - 25094. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Welm, S. Kim, B. E. Welm, and J. M. Bishop MET and MYC cooperate in mammary tumorigenesis PNAS, March 22, 2005; 102(12): 4324 - 4329. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Fischer, S. Giordano, P. M. Comoglio, and A. Ullrich Reactive Oxygen Species Mediate Met Receptor Transactivation by G Protein-coupled Receptors and the Epidermal Growth Factor Receptor in Human Carcinoma Cells J. Biol. Chem., July 9, 2004; 279(28): 28970 - 28978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Slater, E. Koutsouki, C. L. Jackson, R. C. Bush, G. D. Angelini, A. C. Newby, and S. J. George R-Cadherin:{beta}-Catenin Complex and Its Association With Vascular Smooth Muscle Cell Proliferation Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1204 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Graham and A. R. Asthagiri Epidermal Growth Factor-mediated T-cell Factor/Lymphoid Enhancer Factor Transcriptional Activity Is Essential but Not Sufficient for Cell Cycle Progression in Nontransformed Mammary Epithelial Cells J. Biol. Chem., May 28, 2004; 279(22): 23517 - 23524. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wadham, J. R Gamble, M. A Vadas, and Y. Khew-Goodall The Protein Tyrosine Phosphatase Pez Is a Major Phosphatase of Adherens Junctions and Dephosphorylates {beta}-Catenin Mol. Biol. Cell, June 1, 2003; 14(6): 2520 - 2529. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al. Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4 J. Biol. Chem., October 25, 2002; 277(44): 42386 - 42393. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |